PROMETHERA BIOSCIENCES
A bankruptcy procedure is open for PROMETHERA BIOSCIENCES according to publications in the Belgian State Gazette. The file additionally contains 4 judicial reorganisations. The 2022 annual accounts show negative equity (€-1.50M) and a net result of €-520k.
| Equity | €-1.50M |
| Net result | €-520k |
| Better than sector | 5% |
| Active | 17 yrs |
Fragile profile, watch health in particular.
All 5 axes are computed from data Checked has read.
Bankruptcy opened
A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -34.5% | 51.1% | |
| Net result | €-520k | €40k | |
| Equity | €-1.50M | €96k | |
| Gross operating margin | €55k | €114k | |
| Staff costs | €-1k | €227k |
Show 11 other metrics
| Fiscal year | 2022 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | - |
| Net profit | €-520k |
| Cash flow | - |
| Staff costs | €-1k |
| Income taxes | - |
| Dividends | - |
| Total assets | €4.34M |
| Equity | €-1.50M |
| Debt | €5.84M |
| of which ≤ 1y | €2.44M |
| of which > 1y | €3.39M |
| Working capital | €1.83M |
| Employees (FTE) | - |
| 2022 | |
|---|---|
| Current ratio | 1.75 |
| Quick ratio | 1.75 |
| Working capital ratio | 42.3% |
| Solvency | -34.5% |
| Debt / equity | -3.90 |
| Long-term debt ratio | -2.27 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -12.0% |
| ROE | 34.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (21 line items)
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €4.34M |
| Fixed assets | 21/28 | €64k |
| Financial fixed assets | 28 | €64k |
| Current assets | 29/58 | €4.28M |
| Amounts receivable within one year | 40/41 | €4k |
| Cash & bank | 54/58 | €611 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €4.34M |
| Equity | 10/15 | €-1.50M |
| Contributions / capital | 10/11 | €61.71M |
| Reserves | 13 | €17.09M |
| Accumulated profits (losses) | 14 | €-80.29M |
| Amounts payable | 17/49 | €5.84M |
| Amounts payable after one year | 17 | €3.39M |
| Amounts payable within one year | 42/48 | €2.44M |
| Trade debts payable within one year | 44 | €1.58M |
| Income statement | ||
| Gross operating margin | 9900 | €55k |
| Operating result | 9901 | €-500k |
| Financial charges | 65 | €20k |
| Result before taxes | 9903 | €-520k |
| Net result for the period | 9904 | €-520k |
| Result to be appropriated | 9905 | €-455k |
-
Bruno De KeersmaekerDirectorState Gazette act 22058089 (11-05-2022)Current11-05-2022 → present
-
Alick DongDaily management delegateState Gazette act 20132561 (10-11-2020)Current10-11-2020 → present
-
A Q Invest SRLLegal entityDaily management delegateState Gazette act 20132561 (10-11-2020)Current25-09-2020 → present
2 events
- 10-11-2020 Appointed· Daily management delegate
- 25-09-2020 Appointed· Director
-
Chi Tak FokDirectorState Gazette act 20111595 (25-09-2020)Current25-09-2020 → present
-
Etienne SokalDaily management delegateState Gazette act 20132561 (10-11-2020)Current18-11-2019 → present
5 events
- 10-11-2020 Appointed· Daily management delegate
- 10-11-2020 Appointed· Président du conseil d'administration
- 18-11-2019 Resigned· Director
- 18-11-2019 Appointed· Director
- 25-11-2016 Appointed· Administrator
Historic, not recently confirmed (17)
-
Shintaro HayashiDirectorState Gazette act 20069483 (22-06-2020)Not recently confirmedlast confirmed in an act from 2020
-
Charles L. Dimmler IIIAdministrateur indépendantState Gazette act 19149980 (18-11-2019)Not recently confirmedlast confirmed in an act from 2019
3 events
- 18-11-2019 Resigned· Administrateur indépendant
- 18-11-2019 Appointed· Administrateur indépendant
- 03-05-2018 Appointed· Director
-
Edward HaackAdministrateur indépendantState Gazette act 19149980 (18-11-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 18-11-2019 Resigned· Administrateur indépendant
- 18-11-2019 Appointed· Administrateur indépendant
-
Silver Ocean Venture SASDirectorState Gazette act 19149980 (18-11-2019)Not recently confirmedlast confirmed in an act from 2019
-
Edward Walter HaackDirectorState Gazette act 19070920 (27-05-2019)Not recently confirmedlast confirmed in an act from 2019
-
Tetsuya KuriharaDirectorState Gazette act 19045049 (02-04-2019)Not recently confirmedlast confirmed in an act from 2019
-
BDO ATRIO Réviseurs d'entreprisesAuditorState Gazette act 18171665 (30-11-2018)Not recently confirmedlast confirmed in an act from 2018
-
Madame Reiko NamikawaDirectorState Gazette act 18046971 (16-03-2018)Not recently confirmedlast confirmed in an act from 2018
-
Monsieur Charles L. Dimmier IIIDirectorState Gazette act 18046971 (16-03-2018)Not recently confirmedlast confirmed in an act from 2018
-
Monsieur Masaki DoiDirectorState Gazette act 18046971 (16-03-2018)Not recently confirmedlast confirmed in an act from 2018
-
Christof HettichPresidentState Gazette act 16162237 (25-11-2016)Not recently confirmedlast confirmed in an act from 2016
-
Ilka WickeAdministratorState Gazette act 16162237 (25-11-2016)Not recently confirmedlast confirmed in an act from 2016
-
Jean-Paul PrieelsAdministratorState Gazette act 16162237 (25-11-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 25-11-2016 Appointed· Administrator
- 28-06-2016 Appointed· Director
-
John TchelingerianRepresentative of silver ocean ventures sasState Gazette act 16162237 (25-11-2016)Not recently confirmedlast confirmed in an act from 2016
-
Philippe DegiveRepresentative of sparaxis saState Gazette act 16162237 (25-11-2016)Not recently confirmedlast confirmed in an act from 2016
-
BDO ATRIO Réviseurs d'entreprises SCSCRLAuditorState Gazette act 16128379 (16-09-2016)Not recently confirmedlast confirmed in an act from 2016
-
Christof Anton HettichAdministrateur de catégorie bState Gazette act 16063909 (10-05-2016)Not recently confirmedlast confirmed in an act from 2016
Permanent representatives (1)
-
Jean-Paul PrieelsReprésentant permanentState Gazette act 15116602 (12-08-2015)Permanent representative12-08-2015 → present
Former directors (15)
-
Alain ParthoensDaily management delegateState Gazette act 20132561 (10-11-2020)Former25-11-2016 → 11-05-2022
3 events
- 11-05-2022 Resigned· Director
- 10-11-2020 Appointed· Daily management delegate
- 25-11-2016 Appointed· Representative of a q invest sprl
-
Eric FokDirectorState Gazette act 22058089 (11-05-2022)Former- → 11-05-2022
-
Reiko NamikawaAdministrateur indépendantState Gazette act 19149980 (18-11-2019)Former03-05-2018 → 11-05-2022
4 events
- 11-05-2022 Resigned· Director
- 18-11-2019 Resigned· Administrateur indépendant
- 18-11-2019 Appointed· Administrateur indépendant
- 03-05-2018 Appointed· Director
-
Zimeng DongDirectorState Gazette act 20111595 (25-09-2020)Former25-09-2020 → 23-02-2022
2 events
- 23-02-2022 Resigned· Director
- 25-09-2020 Appointed· Director
-
Charles DimmlerAdministrateur, président du conseil d'administrationState Gazette act 20132561 (10-11-2020)Former- → 10-11-2020
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Didier DelanoyeCurrent Commissaire |
- | 23-02-2022 → present |
Show 2 earlier auditors
| Luc Annick Commissaire |
- | - → 28-06-2016 |
| Noëlle Lucas Commissaire succeeded by Didier Delanoye in 2022 |
- | 28-06-2016 → 23-02-2022 |
| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | RODOLPHE DE SAN RUE DE CLAIRVAUX 40,
1348 LOUVAIN-LA-NEUVE |
27-05-2024 → present | Belgian State Gazette |
| NACE primary | Activiteiten op het gebied van voeding(86995) |
| Legal form | Public limited company(014) |
| Incorporation | 12-02-2009 |
| Status | Active |
| Postal code | 1435 |
| First BS signal | 18-12-2020 |
| Latest BS signal | 31-05-2024 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonia | 6.2 ha | 1 · 17 m² | 7.8 m · 2 fl. |
| 52028B0323/00M003 | Wallonia | 8,679 m² | 1 · 791 m² | 18.8 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
The full chronology lists every recorded event with its date, the competent court and the appointed liquidator or administrator. It answers at which stage the proceedings stand and whether they are still running.
We hold 4 further earlier events in this file, covering 14-12-2020 to 27-05-2024.
We know of 50 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
11-05-2022 1 director appointed, 3 resigning
- Bruno De Keersmaeker, Bestuurder
- Eric Fok, Bestuurder
- Alain Parthoens, Bestuurder
- Reiko Namikawa, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Eric Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Bruno De Keersmaeker",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}23-02-2022 1 director appointed, 1 resigning
- Didier Delanoye, Commissaire
- Zimeng Dong, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}09-02-2022 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-01-28",
"act_kind_objet": "CESSION DE BRANCHE D\u0027ACTIVITES"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2022-01-17",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0809.788.365",
"name": "PROMETHERA BIOSCIENCES",
"role": "contributor",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0764.522.425",
"name": "Promethera Therapeutics",
"role": "recipient",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103",
"12:93",
"12:94",
"12:95",
"12:97",
"12:98",
"12:99",
"12:100"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2021-02-23",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La cession concerne une branche d\u0027activit\u00E9 au sens de l\u0027article 12:11 du Code des soci\u00E9t\u00E9s et des associations, comprenant l\u0027ensemble des actifs (y compris les cr\u00E9ances), passifs, droits et obligations aff\u00E9rents aux \u00E9l\u00E9ments d\u00E9crits \u00E0 l\u0027annexe 1 du Projet Commun de Cession. Cette branche est technique et organisationnellement autonome, et peut fonctionner de mani\u00E8re ind\u00E9pendante.",
"equity_transferred_eur": null,
"accounting_effective_date": "2021-03-30"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null
},
"summary_narrative": "La soci\u00E9t\u00E9 anonyme PROMETHERA BIOSCIENCES a c\u00E9d\u00E9 \u00E0 titre on\u00E9reux, \u00E0 la soci\u00E9t\u00E9 anonyme Promethera Therapeutics, une branche d\u0027activit\u00E9 constitu\u00E9e d\u0027actifs, passifs, droits et obligations li\u00E9s \u00E0 une activit\u00E9 autonome, conform\u00E9ment aux dispositions de l\u0027article 12:103 du Code des soci\u00E9t\u00E9s et des associations. Le transfert a \u00E9t\u00E9 effectu\u00E9 \u00E0 compter du 30 mars 2021, et les op\u00E9rations relatives \u00E0 cette branche sont comptabilis\u00E9es comme si elles avaient \u00E9t\u00E9 r\u00E9alis\u00E9es par la soci\u00E9t\u00E9 b\u00E9n\u00E9ficiaire.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte"
],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}10-11-2020 5 directors appointed, 2 resigning
- Etienne Sokal, Dagelijks bestuur
- A Q Invest SRL, Dagelijks bestuur
- Alain Parthoens, Dagelijks bestuur
- Alick Dong, Dagelijks bestuur
- Etienne Sokal, Président du conseil d'administration
- Silver Ocean Ventures SAS, Administrateur, administrateur délégué
- Charles Dimmler, Administrateur, président du conseil d'administration
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur, administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Silver Ocean Ventures SAS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alick Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur, pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Charles Dimmler",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-09-2020 3 directors appointed
- Zimeng Dong, Bestuurder
- Chi Tak Fok, Bestuurder
- A Q Invest SRL, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Chi Tak Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-09-2020 Masaki Doi resigns as administrateur indépendant
- Masaki Doi, Administrateur indépendant
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur ind\u00E9pendant",
"person": {
"rrn": null,
"name": "Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}22-06-2020 1 director appointed, 1 resigning
- Shintaro Hayashi, Bestuurder
- Tajio Enoki, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Shintaro Hayashi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-02-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}09-01-2020 Capital increase of €3,318,312.22 to €20,318,312.22
- €17.000.000 → €20.318.312,22
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 20318312.22,
"delta_eur": 3318312.219999999,
"before_eur": 17000000.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-12-2019 Capital increase of €338,246.60 to €19,977,982.14
- €19.639.735,54 → €19.977.982,14
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19977982.14,
"delta_eur": 338246.6000000015,
"before_eur": 19639735.54,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-12-2019 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-11-2019 Capital increase of €135,112.50 to €19,639,735.54
- €19.504.623,04 → €19.639.735,54
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19639735.54,
"delta_eur": 135112.5,
"before_eur": 19504623.04,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-09-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-05-2019 Capital increase of €11,311,354.92 to €19,449,363.08
- €8.138.008,16 → €19.449.363,08
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19449363.08,
"delta_eur": 11311354.919999998,
"before_eur": 8138008.16,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-04-2019 1 director appointed, 1 resigning
- Tetsuya Kurihara, Bestuurder
- Kinji Fuchikami, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Kinji Fuchikami",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tetsuya Kurihara",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}19-02-2019 Tajio Enoki appointed as director
- Tajio Enoki, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}10-01-2019 Capital increase of €54,281.25 to €10,760,883.85
- €10.706.602,60 → €10.760.883,85
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10760883.85,
"delta_eur": 54281.25,
"before_eur": 10706602.6,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}07-12-2018 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-11-2018 BDO ATRIO Réviseurs d'entreprises appointed as auditor
- BDO ATRIO Réviseurs d'entreprises, Auditor
Technical details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "BDO ATRIO R\u00E9viseurs d\u0027entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "Promethera Biosciences"
}
}23-08-2018 Capital increase of €52,687.50 to €10,706,602.60
- €10.653.915,10 → €10.706.602,60
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10706602.6,
"delta_eur": 52687.5,
"before_eur": 10653915.1,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-07-2018 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}08-06-2018 Capital increase of €1,153.53 to €10,653,915.10
- €10.652.761,57 → €10.653.915,10
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10653915.1,
"delta_eur": 1153.5299999993294,
"before_eur": 10652761.57,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-05-2018 Capital increase of €1,033,579.39 to €10,652,761.57
- €9.619.182,18 → €10.652.761,57
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10652761.57,
"delta_eur": 1033579.3900000006,
"before_eur": 9619182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}03-05-2018 Capital increase of €8,735,000 to €9,619,182.18
- €884.182,18 → €9.619.182,18
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9619182.18,
"delta_eur": 8735000.0,
"before_eur": 884182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}16-03-2018 3 directors appointed, 3 resigning
- Madame Reiko Namikawa, Bestuurder
- Monsieur Charles L. Dimmier III, Bestuurder
- Monsieur Masaki Doi, Bestuurder
- Sparaxis SA, Bestuurder
- Madame Ilka Wicke, Bestuurder
- Monsieur Jean-Paul Prieels, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sparaxis SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Ilka Wicke",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Jean-Paul Prieels",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Charles L. Dimmier III",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}12-10-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}01-09-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}21-06-2017 Capital increase of €112,162.50 to €8,841,873.44
- €8.729.710,94 → €8.841.873,44
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8841873.44,
"delta_eur": 112162.5,
"before_eur": 8729710.94,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}04-01-2017 Capital increase of €0.01 to €8,729,710.94
- €8.729.710,93 → €8.729.710,94
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8729710.94,
"delta_eur": 0.009999999776482582,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-11-2016 Capital increase of €990.99 to €8,730,701.92
- €8.729.710,93 → €8.730.701,92
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8730701.92,
"delta_eur": 990.9900000002235,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}| Legal nameFR | PROMETHERA BIOSCIENCES |